SCHEMBL31140564

SCHEMBL31140564

O=C(O)c1ccc2nc(O)n(CC3CCO3)c2c1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 2/20 0.48
▸ GLP1R P43220 17/20 0.46
▸ ACSS2 Q9NR19 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31140527 0.90 PTGER4 (0.58) PTGER4
SCHEMBL29770328 0.89 PTGER4 (0.52) PTGER4GLP1RACSS2
SCHEMBL23980750 0.89 PTGER4 (0.52) PTGER4GLP1RACSS2
SCHEMBL30497392 0.88 GLP1R (0.49) PTGER4GLP1R
SCHEMBL29149774 0.86 GLP1R (0.50) GLP1R
SCHEMBL29149777 0.86 GLP1R (0.50) GLP1R
SCHEMBL20266409 0.85 GLP1R (0.50) GLP1R
SCHEMBL24529616 0.85 GLP1R (0.51) PTGER4GLP1R
SCHEMBL20266411 0.85 GLP1R (0.50) GLP1R
SCHEMBL24338858 0.85 GLP1R (0.50) GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568664-A1 COMBINATION COMPRISING A THR-BETA AGONIST AND A GLP-1R AGONIST FOR USE IN TREATING A LIVER DISORDER OR A CARDIOMETABOLIC DISEASE Terns Pharmaceuticals, Inc. (US) 2025-06-18 — — EP disclosed
WO-2024211898-A1 COMBINATION COMPRISING A THRBETA AGONIST ANDA GLP-1R AGONIST FOR USE IN TREATING A LIVER DISORDER OR A CARDIOMETABOLIC DISEASE TERNS PHARMACEUTICALS, INC. (US) 2024-10-10 — — WO disclosed
Send feedback